Hi, what are you looking for?
Jewish Business News
Search results for " Teva Pharmaceutical"
Business
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Please help us...
Business
– Pfizer will pay $295 million for the growth hormone treatment and up to $275 million in milestone payments, and royalties. Pfizer Inc. (NYSE:...
Business
– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and...
Business
On Monday, NewLink Genetics announced it has made a deal with drug maker Merck, to research, develop, manufacture and distribute an experimental Ebola vaccine,...
Business
“Bloomberg” has raised the possibility that Israel Chemicals Ltd. (TASE: ICL) could take advantage of its imminent public offering on the New York...
Business
– Multiple sclerosis treatment Copaxone accounts for an estimated half of Teva’s profit. – Changes in the multiple sclerosis treatment market, in which...
Business
– The Israeli biomedical company now faces competition for both of its drugs. – The share price of Protalix Biotherapeutics Inc. (NYSE MKT:PLX; TASE:...
Business
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
World News
– Pharmaceutical company Perrigo has yet to be sold and already major business publications are speculating on what its sale will mean to the TASE....
Syndicated
The Annual Drug Repositioning, Repurposing & Rescue Conference announces Bruce Bloom of Cures Within Reach and Aris Persidis of Biovista as conference chairs.